Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Allena Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 29 | 36 | +7 |
| Shares | 21.6M | 19.9M | −1.70M (−7.9%) |
| Value | $28.1M | $18.0M | −$10.1M (−36.1%) |
New holders (10)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 1,067,886 | $963.0K | 0.26% |
| Gsa Capital Partners LLP | 152,731 | $138.0K | 0.01% |
| Two Sigma Securities, LLC | 83,689 | $76.0K | 0.02% |
| Jane Street Group, LLC | 53,964 | $49.0K | 0.00% |
| Quilter Plc | 52,204 | $47.0K | 0.00% |
| Natixis | 50,000 | $45.0K | 0.00% |
| Spire Wealth Management | 50,000 | $45.0K | 0.00% |
| XTX Topco Ltd | 21,443 | $19.0K | 0.01% |
| Susquehanna International Group, LLP | 14,339 | $13.0K | 0.00% |
| Victory Capital Management Inc | 11,060 | $10.0K | 0.00% |
Sold out (3)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 3,000,000 | $3.90M |
| Millennium Management LLC | 187,431 | $244.0K |
| Bank of New York Mellon Corp | 34,026 | $44.0K |